$CB

Goldman Sachs Adjusts Price Target on Chubb to $391 From $386, Maintains Buy Rating

Goldman Sachs raised its price target on Chubb to $391 from $386 while maintaining a buy rating. Chubb's stock closed at $325.25, down 2.06% for the day and 2.97% for the week, but up 4.21% year-to-date.

Original reporting
Published Oct 1, 2026, 10:54 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 11:16 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CB
Bullish
medium confidence
Mentioned
$CB
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$CBBullishLow
01

Why it matters

The target increase is a small upward revision that may prompt short‑term buying interest.

02

Market read

A modest analyst target raise for CB with limited immediate trading impact.

03

What to watch

Potential upcoming earnings or macro‑insurance trends could amplify the move.

Relevance 5/10Novelty 5/10Timing: pre‑market today

Background

Goldman Sachs periodically updates price targets for covered stocks; this is a routine analyst note.

Company-level read

Ticker impact

$CBBullishMedium confidence
Context

Goldman Sachs raised Chubb's price target to $391 from $386, maintaining a Buy rating.

Expected impact

likely upward pressure as the market prices in the higher target

Evidence & confidence

A small target bump signals confidence but the magnitude is limited, so any price move should be modest.

Market effects

Minor impact on the insurance sector as analysts adjust expectations for Chubb.

Limited to U.S. equity markets; no broader regional effect.

Low global relevance; only affects investors tracking Chubb.

Counterpoint

The target raise is modest and may already be priced in, limiting upside.

Key entities

  • Goldman Sachs

    Equity research firm issuing the target revision.

  • Chubb Limited

    U.S. insurer whose ticker is CB.

Related articles

$CBMed

Fed hikes again - an AI-Picked insurer is still cashing in

The Federal Reserve raised rates, impacting markets. Investing.com's AI models show varied portfolio performance. Chubb (CB) is benefiting from higher rates, with a 1.13% monthly gain, due to its Treasury investments. CB's earnings beat estimates, and it trades at a low forward P/E. The Fed's decision is affecting sectors differently.

$CBMed

Is Wall Street Bullish or Bearish on Chubb Limited Stock?

Chubb Limited (CB), a global insurer, has seen its stock rise 26% over the past year, outpacing the S&P 500. In 2026, it gained 10.2%, underperforming the index. CB offers a 1.20% dividend yield and has increased payouts for 18 years. Analysts expect 10.7% EPS growth this year. The consensus rating is 'Moderate Buy' with a mean price target of $369.36, suggesting 6.1% upside.

$CBMed

What Chubb (CB)'s Earnings Beat and Completed Buyback Mean For Shareholders

Chubb Limited (CB) reported Q2 2026 earnings above analyst estimates, citing higher underwriting and investment income and 3.6% net premium written growth across Property & Casualty and Life. The company also completed a US$4.45 billion multi-year buyback totaling 14,811,112 shares. Chubb Tempest Re named James Wixtead Executive Chairman and Michael O’Donnell President.